Please do not adjust margins
RSC Advances
Page 8 of 10
ARTICLE
Journal Name
Spectral data for the selected amides
applications in other palladium transformations in the future.
DOI: 10.1039/C6RA18679C
N-Cyclohexylbenzamide (4b). 1H-NMR (250 MHz, CDCl3) δ
(ppm): 7.70 (dd, J = 7.5, 2.4 Hz, 2H), 7.40–7.30 (m, 3H), 6.00 (s,
1H), 3.95–3.85 (m, 1H), 1.97–1.90 (m, 2H), 1.73–1.54 (m, 2H),
1.38–1.12 (m, 6H); 13C-NMR (62.9 MHz, CDCl3) δ (ppm): 166.5,
135.0, 131.3, 128.5, 126.7, 48.5, 33.2, 25.6, 25.0; m/z (%) = 203
Acknowledgements
We gratefully acknowledge the funding support received for
this project from the Isfahan University of Technology (IUT), IR
Iran (A.R.H.) and Grant GM 33138 (A.E.R.) from the National
Institutes of Health, USA. Further financial support from the
Center of Excellence in Sensor and Green Chemistry Research
(IUT) is gratefully acknowledged.
1
N-Benzylbenzamide (4d). H NMR (250 MHz, CDCl3) δ (ppm):
7.73 (2H, d, J = 7.6 Hz), 7.24–7.43 (8H, m), 6.38 (1H, br s), 4.58
(2H, d, J = 5.6 Hz); 13C NMR (62.9 MHz, CDCl3) δ (ppm): 44.0,
127.1, 127.4, 127.8, 128.5, 128.7, 131.5, 134.4, 138.4, 167.6;
m/z (%) = 211
N-Benzyl-N-methylbenzamide (4e). bp: 213
bp: 212 °C/10 Torr); H NMR (250 MHz, CDCl3) δ (ppm): 7.09
7.40 (10H, m), 4.68 (1H, br s), 4.44 (1H, br s), 2.95 (1.5H, br s),
2.77 (1.5H, br s); IR (KBr disk) ν (cm-1) 3034, 2935, 2850, 1637,
1500, 1453, 1385, 1254, 1067, 700; m/z (%) = 226
–
215/10 Torr, (lit.
Notes and references
1
–
1
A. Brennfuhrer, H. Neumann and M. Beller, Angew. Chem.
Int. Ed., 2009, 48, 4114.
a) X. F. Wu, H. Neumann and M. Beller, Chem. Soc. Rev.,
2011, 40, 4986; b) M. Seayad, J. Seayad, P. L. Mills and R. V.
Chaudhari, Ind. Eng. Chem. Res., 2003, 42, 2496; c) S. P.
Gupte, V. P. Krishnamurthy and R. V. Chaudhari, Chem. Eng.
Sci., 1996, 51, 2069.
2
N-Benzyl-2-methylbenzamide (4g). 1H NMR (250 MHz, CDCl3) δ
(ppm): 7.13–7.34 (9H, m), 6.11 (1H, br s), 4.60 (2H, d, J = 5.6
Hz), 2.38 (3H, s); 13C NMR (62.9 MHz, CDCl3) δ (ppm): 169.9,
138.2, 136.2, 136.1, 131.0, 129.9, 128.7, 127.8, 127.5, 126.7,
125.7, 43.9, 19.8; m/z (%) = 225
3
4
5
6
7
8
9
H. Neumann, A. Brennfuhrer and M. Beller, Chem. Eur. J.,
2008, 14, 3645.
Z. Zhang, Y. Liu, M. Gong, X. Zhao, Y. Zhang and J. Wang,
Angew. Chem. Int. Ed., 2010, 49, 1139.
X. F. Wu, H. Neumann, A. Spannenberg, T. Schulz, H. Jiao and
M. J. Beller, J. Am. Chem. Soc., 2010, 132, 14596.
Q. Liu, G. Li, J. He, J. Liu, P. Li and A. Lei, Angew. Chem. Int.
Ed., 2010, 49, 3371.
X. F. Wu, H. Neumann and M. Beller, Angew. Chem. Int. Ed.,
2010, 49, 5284.
N. Iranpoor, H. Firouzabadi, E. Etemadi-Davan, A.
Nematollahi and H. R. Firouzi, New J. Chem., 2015, 39, 6445.
T. Sugihara, C. Coperet, Z. Owczarcy, L. S. Haring and E. J.
Negishi, J. Am. Chem. Soc., 1994, 116, 7923.
1
N-Benzyl-4-cyanobenzamide (4h). H-NMR (250 MHz, CDCl3) δ
(ppm): 7.88 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.36–
7.26 (m, 5H), 6.86 (s, 1H), 4.58 (d, J = 6.0 Hz, 2H); 13C-NMR
(62.9 MHz, CDCl3) δ (ppm): 165.7, 138.2, 137.7, 132.3, 131.8,
128.6, 127.8, 127.7, 118.0, 115.0, 44.2; m/z (%) = 236
1
N-(4-Methoxybenzyl)benzamide (4j). H NMR (250 MHz, CDCl3)
δ (ppm): 7.70 (2H, d, J = 8.2 Hz), 7.44–7.30 (3H, m), 7.20 (2H, d,
J¼8.4 Hz), 6.80 (2H, d, J = 8.6 Hz), 6.38 (1H, br s), 4.50 (2H, d, J
= 5.4 Hz), 3.72 (3H, s); 13C NMR (62.9 MHz, CDCl3) δ (ppm):
166.2, 158.1, 133.4, 130.5, 129.2, 128.3, 127.5, 125.9, 113.1,
54.3, 42.6; m/z (%) = 241
10 a) M. V. Khedkar, T. Sasaki and B. M. Bhanage, ACS Catal.,
2013, , 287; b) V. R. Pattabiraman and J. W. Bode, Nature,
3
2011, 480, 471; c) T. Cupido, J. Tulla-Puche, J. Spengler and F.
Albericio, Curr. Opin. Drug Discovery Dev., 2007, 10, 768; d)
C. Locatelli, F. B. Filippin-Monteiro and T. B. Creczynski-Pasa,
Eur. J. Med. Chem., 2013, 60, 233; e) A. C. Fonseca, M. H. Gil
and P. N. Simoes, Prog. Polym. Sci., 2014, 39, 1291.
11 K. Ishihara, Tetrahedron, 2009, 65, 1085.
N-Phenyl-4-methylbenzamide (4l). 1H NMR (250 MHz, CDCl3) δ
(ppm): 2.34 (3H, s), 7.09 (2H, d, J = 7.5 Hz), 7.21 (d, 2H, J =
7.73 Hz), 7.30 (1H, t), 7.57 (2H, d, J = 8.3 Hz), 7.70 (2H, d, J =
8.2 Hz), 7.80 (1H, br s); 13C NMR (62.9 MHz, CDCl3) δ (ppm):
21.4, 120.2, 124.4, 127.1, 129.0, 129.4, 132.1, 138.1, 142.3,
165.8; m/z (%) = 211
12 M. Beller, B. Cornils, C. D. Frohning and C. W. J. Kohlpaintner,
J. Mol. Catal. A: Chem., 1995, 104, 17.
13 J. Wannberg and M. J. Larhed, Org. Chem., 2003, 68, 5750.
14 H. U. Blaser, M. Diggelmann, H. Meier, F. Naud, E.
Scheppach, A. Schnyder and M. J. Studer, Org. Chem., 2003,
68, 3725.
Conclusions
15 C. M. Kormos and N. E. Leadbeater, Org. Biomol. Chem.,
2007, 5, 65.
In conclusion, we have developed the preparation and
characterization of magnetic chitosan-supported Pd(0)
complex and its successful applications for the
alkoxycarbonylation and aminocarbonylation of aryl iodides
with alcohols and amines in the presence of Mo(CO)6. Both
electron-rich and electron-deficient aryl iodides could be
applied for the transformation. The ImmPd(0)-MNPs catalyst
was very stable and could be reused easily by an external
magnet without activity loss. Moreover, the present catalyst
can be synthesized readily from inexpensive and commercially
available starting materials. We believe that this catalyst
16 J. Liu, B. Liang, D. Shu, Y. Hub, Z. Yang and A. Lei,
Tetrahedron, 2008, 64, 9581.
17 E. Mizushima, T. Hayashi and M. Tanka, Green Chem., 2001,
3
, 76.
18 M. A. Mercadante and N. E. Leadbeater, Org. Biomol. Chem.,
2011, , 6575.
9
19 C. B. Kelly, C. Lee, M. A. Mercadante and N. E. Leadbeater,
Org. Process Res. Dev., 2011, 15, 717.
20 K. Kumar, A. Zapf, D. Michalik, A. Tillack, T. Heinrich, H.
Bottcher, M. Arlt and M. Beller, Org. Lett., 2004, 6, 7.
21 A. Schoenberg, I. Bartoletti and R. F. Heck, J. Org. Chem.,
1974, 39, 3318.
22 a) W. Fang, Q. Deng, M. Xu and T. Tu, Org. Lett., 2013, 15
,
3678; b) T. T. Dang, Y. Zhu, J. S. Y. Ngiam, S. C. Ghosh, A.
8 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins